All posts by PIER MARIA FORNASARI

Critical step in COVID viral infection identified

Researchers at Texas Biomedical Research Institute and University of Chicago have uncovered a mechanism that SARS-CoV-2, the virus that causes COVID-19, uses to protect itself inside the body as it works to replicate and infect more cells. Without this protective mechanism, viral infection is dramatically reduced. The finding, published in Nature Communications, not only provides a

Read More


American Academy Neurology issues Evidence in Focus article on Duchenne muscular dystrophy gene therapy

To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of Neurology (AAN) has issued an Evidence in Focus article, published May 14, 2025, online in Neurology®. AAN Evidence in Focus articles highlight the strength of the current evidence for

Read More


Chapman University Contributes to Innovation: AI-Powered App Enables Anemia Screening Using Fingernail Selfies

The study showed that personalized app use in participating patients improved accuracy by nearly 50% for millions at risk for anemia. Anemia affects more than 2 billion people worldwide, including an estimated 83 million Americans at high risk. Now, a new app delivers reliable, accessible screening directly to consumers. A new study co-authored by Chapman University

Read More


FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease

New Test Provides Less Invasive Option, Reduces Reliance on PET Scans and Increases Diagnosis Accessibility The U.S. Food and Drug Administration cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated

Read More


Vagus Nerve Stimulation Clinical Trial Shows Improvements for Spinal Cord Injuries

In a new clinical study, researchers from the Texas Biomedical Device Center (TxBDC) at The University of Texas at Dallas demonstrated unprecedented rates of recovery for spinal cord injuries. In this study, published in the prestigious journal Nature on May 21, individuals with incomplete spinal cord injury safely received a combination of stimulation of a nerve in the neck

Read More


More Evidence Links Physical Activity With Improved Cancer Survival, New ACS Study Finds

American Cancer Society researchers stress the need for survivors to incorporate physical activity into their daily routine A new large analysis led by American Cancer Society (ACS) researchers shows engaging in leisure-time moderate-to-vigorous physical activity (MVPA) after a cancer diagnosis improves survival for people with several cancer types, including bladder, breast, colon, endometrial, kidney, lung, oral, prostate,

Read More


World’s first patient treated with personalized CRISPR gene editing therapy through CHOP and Penn Med collaboration

A landmark study from CHOP and Penn Medicine showcases the power of customized gene editing therapy to treat a patient with a rare metabolic disease In a historic medical breakthrough, a child diagnosed with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy by a team at Children’s Hospital of

Read More


Skip the Extra Salt: Study Shows Heart Healthy Diet and Sodium Reduction Lower Risk of Heart Disease

Reducing Sodium and Following Heart Healthy Diet Lower 10-Year Risk of Heart Disease Most Americans consume far more sodium than recommended, with the average intake topping 3,400 milligrams (mg) per day—well above the recommended federal guideline of 2,300 mg and the American Heart Association’s goal of 1,500 mg. The bulk of American’s daily sodium doesn’t

Read More